Feasibility, acceptability, and utility of a nurse-led survivorship program for people with metastatic melanoma (MELCARE)

PURPOSE: Immune checkpoint inhibitors (ICIs) and targeted therapy (TT) have improved the survival of people with metastatic melanoma. We assessed the feasibility, acceptability, and utility of a novel model of nurse-led, telehealth-delivered survivorship care (MELCARE) for this survivor group. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai-Kwon, Julia, Kelly, Brooke, Lane, Sarah, Biviano, Rebecca, Bartula, Iris, Brennan, Frank, Kivikoski, Ingrid, Thompson, Jake, Dhillon, Haryana M., Menzies, Alexander, Long, Georgina V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492451/
https://www.ncbi.nlm.nih.gov/pubmed/36136246
http://dx.doi.org/10.1007/s00520-022-07360-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492451/
https://www.ncbi.nlm.nih.gov/pubmed/36136246
http://dx.doi.org/10.1007/s00520-022-07360-4

Ejemplares similares